COL11A2 as a candidate gene for vertebral malformations and congenital scoliosis
Saturday, April 23, 2022
1:45 PM – 2:00 PM US MT
Location: Convention Center: 603
CE: Enduring CME: 0.25
Publication Number: 1495.3
Philip F. Giampietro, University of Illinois-Chicago, Chicago, IL, United States; Denise E. Rebello, University of Toronto Temerty Faculty of Medicine, Toronto, ON, Canada; Elizabeth Wohler, Johns Hopkins University School of Medicine, Baltimore, MD, United States; Nara Sobreira, Johns Hopkins University School of Medicine, Baltimore, MD, United States; Cathy Raggio, Hospital for Special Surgery, NY, ND, United States; Christina A. Gurnett, St Louis Children's Hospital, St Louis, MO, United States; Nan Wu, Peking Union Medical College Hospital, Beijing, Beijing, China (People's Republic); Alberto S. Cornier, Ponce Health Sciences University/San Jorge Children's Hospital, San Juan, N/A, Puerto Rico; Steven Hwang, Shriners hospital for children, Philadelphia, PA, United States; Robert D. Steiner, University of Wisconsin School of Medicine and Public Health and Marshfield Clinic Research Institute, Marshfield, WI, United States; Brian Ciruna, The Hospital for Sick Children, Toronto, ON, Canada
Presenting Author(s)
Philip F. Giampietro, MD PhD
Professor of Pediatrics University of Illinois-Chicago Chicago, Illinois, United States
Participants should be aware of the following financial/non-financial relationships:
Philip F. Giampietro, MD PhD: ● NIH R03 HD099516-01A1 (Products/Services: Research Support including clinical trials & the principal or named investigator).
Denise E. Rebello, BSc Molecular Biology and Genetics: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Elizabeth Wohler, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Nara Sobreira, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Cathy Raggio, MD: ● Biomarin (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Consultant, Advisory Committee). ● Nextcure (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator).
Christina A. Gurnett, Gurnett, MD PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Nan Wu, M.D.: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Alberto S. Cornier, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Steven Hwang, Md: ● Auctus (Currently Ongoing) (Products/Services: Intellectual Property including patent beneficiary and royalties, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds). ● Nass (Currently Ongoing) (Products/Services: Board Member or Executive Role). ● Nuvasive (Ended In the Past 24 Months) (Products/Services: Consultant, Speaker Honorarium including speakers bureau, symposia, and expert witness). ● Zimmer-Biomet (Ended In the Past 24 Months) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness).
Robert D. Steiner, Steiner, MD: ● Acer Therapuetics (Currently Ongoing) (Products/Services: Consultant, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds). ● Aeglea (Currently Ongoing) (Products/Services: Consultant). ● Alexion (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● Best Doctors (Currently Ongoing) (Products/Services: Consultant). ● Leib Knott Gaynor (Currently Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness). ● Medscape (Currently Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness). ● PreventionGenetics (Currently Ongoing) (Products/Services: Employment with an ineligible company). ● PTC Therapeutics (Currently Ongoing) (Products/Services: Consultant, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds). ● Saalfield Chad (Currently Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness). ● Travere (Products/Services: Consultant).
Brian Ciruna, Ph.D.: I do not have any relevant financial / non-financial relationships with any proprietary interests.
